0027333 - MBÚ 2006 RIV SIGLE GB eng C - Conference Paper (international conference)
Mrkvan, Tomáš - Šírová, Milada - Etrych, Tomáš - Chytil, Petr - Strohalm, Jiří - Plocová, Daniela - Ulbrich, Karel - Říhová, Blanka
Chemotherapy based on HPMA conjugates with pH-controlled release of doxorubicin induces anti-tumour immunity.
[Chemoterapie založená na konjugátech HPMA s pH-řízeným uvolňováním doxorubicinu vede ke vzniku protinádorové imunity.]
Nanomedicines of the Future – Scotland-Czech Republic Drug Delivery Workshop. Glasgow, 2005, s. 25-26.
[Nanomedicines of the Future – Scotland-Czech Republic Drug Delivery Workshop. Glasgow (GB), 18.11.2005-18.11.2005]
Institutional research plan: CEZ:AV0Z50200510
Keywords : Chemotherapy * hpma * doxorubicin
Subject RIV: EE - Microbiology, Virology
Permanent Link: http://hdl.handle.net/11104/0117445